Docetaxel (RP 56976)

This product is for research use only, not for human use. We do not sell to patients.

Docetaxel (RP 56976)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
2g$245In Stock
5g$290In Stock
10g$566In Stock

Cat #: V1604 CAS #: 114977-28-5 Purity ≥ 98%

Description: Docetaxel (formerly known as RP56976; NSC628503; RP-56976; NSC-628503; Taxotere), a semisynthetic analog of paclitaxel and approved anticancer drug, is a mitotic inhibitor and tubulin inhibitor that inhibits the depolymerization of microtubules by binding to and stabilizing microtubules.

References: Attia RT, et al. The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells. PeerJ. 2016 Jun 29;4:e2168.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)807.88
Molecular FormulaC43H53NO14
CAS No.114977-28-5
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 100 mg/mL (123.8 mM)r
Water:<1 mg/mLr
Ethanol: 53 mg/mL (65.6 mM)
Solubility In Vivo5% DMSO+30% PEG 300+5% Tween 80+ddH2O: 2 mg/mL
SynonymsRP56976; NSC 628503; RP-56976; NSC628503; RP 56976; NSC-628503; Docetaxel hydrate, Trade name: Taxotere. Chemical Name: (2aR,4S,4aS,6R,9S,11S,12S,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. SMILES Code: O=C(O[C@@H](C1[C@@]2(C)[C@@H](O)C[C@@]3([H])OC[C@]31OC(C)=O)[C@]4(O)C[C@H](OC([C@H](O)[C@@H](NC(OC(C)(C)C)=O)C5=CC=CC=C5)=O)C(C)=C(C4(C)C)[C@@H](O)C2=O)C6=CC=CC=C6
ProtocolIn VitroSingle and combined treatments of Docetaxel (RP-56976) and glucosamide (GLU) affect cell viability in a dose-dependent manner. IC of GLU in PC-3 and LNCaP cells5070±4 μM and 86.8±8 μM, respectively. Meanwhile, in PC-3 and LNCaP cells, Docetaxel's IC alone was used50 3.08±0.4 nM and 1.46±0.2 nM GLU were treated in combination with Docetaxel for synergistic cytotoxicity, PC-3 and LNCaP cell ICs, respectively50 Values are reduced to 2.7±0.1 nM and 0.75±0.3 nM, respectively
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.2378 mL6.1890 mL12.3781 mL24.7562 mL
5mM0.2476 mL1.2378 mL2.4756 mL4.9512 mL
10mM0.1238 mL0.6189 mL1.2378 mL2.4756 mL
20mM0.0619 mL0.3095 mL0.6189 mL1.2378 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.